 Home > Medical News > Latest Medical News > Zhongsheng Pharmaceutical's FGFR4 inhibitor compound patent was authorized by the U.S. Patent Office

Zhongsheng Pharmaceutical's FGFR4 inhibitor compound patent was authorized by the U.S. Patent Office

 Last Update: 2021-06-29
 Source: Internet
 Author: User

Tags

united states logo

mrna cancer treatment

alcohol dehydrogenase inhibitor

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 16, Guangdong Zhongsheng Pharmaceutical issued an announcement and received a patent certificate issued by the United States Patent and Trademark Office.
The name of the invention is FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF, and the Chinese name is: FGFR4 inhibitor and its preparation method and application
.

Patent number: 11,008,292, the patent expires on November 16, 2037

This patent is a compound patent for the innovative drug ZSP1241 project deployed by Zhongsheng Pharmaceutical in the field of anti-tumor, and belongs to the core patent of the project
.

Currently, ZSP1241 tablets for the treatment of advanced malignant tumors such as liver cancer and gastric cancer are undergoing phase I clinical trials

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.